Year |
Citation |
Score |
2018 |
Smilovic IG, Cluzeau J, Richter F, Nerdinger S, Schreiner E, Laus G, Schottenberger H. Synthesis of enantiopure antiobesity drug lorcaserin. Bioorganic & Medicinal Chemistry. PMID 29496415 DOI: 10.1016/J.Bmc.2018.02.038 |
0.368 |
|
2017 |
Cluzeau J, Stavber G. Development and optimization of a new synthetic process for lorcaserin. Bioorganic & Medicinal Chemistry. PMID 29254893 DOI: 10.1016/J.Bmc.2017.12.009 |
0.342 |
|
2011 |
Troiani V, Cluzeau J, Časar Z. Application of chemoselective pancreatin powder-catalyzed deacetylation reaction in the synthesis of key statin side chain intermediate (4 R,6 S)-4-(tert-butyldimethylsilyloxy)-6-(hydroxymethyl)tetrahydropyran-2-one Organic Process Research and Development. 15: 622-630. DOI: 10.1021/op100341m |
0.314 |
|
2008 |
Suzuki Y, Cluzeau J, Hara T, Hirasawa A, Tsujimoto G, Oishi S, Ohno H, Fujii N. Structure-activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines. Archiv Der Pharmazie. 341: 554-61. PMID 18763715 DOI: 10.1002/Ardp.200700269 |
0.368 |
|
2007 |
Tomita K, Oishi S, Cluzeau J, Ohno H, Navenot JM, Wang ZX, Peiper SC, Akamatsu M, Fujii N. SAR and QSAR studies on the N-terminally acylated pentapeptide agonists for GPR54. Journal of Medicinal Chemistry. 50: 3222-8. PMID 17579384 DOI: 10.1021/Jm070064L |
0.428 |
|
2007 |
Cluzeau J, Oishi S, Ohno H, Wang Z, Evans B, Peiper SC, Fujii N. Design and synthesis of all diastereomers of cyclic pseudo-dipeptides as mimics of cyclic CXCR4 pentapeptide antagonists. Organic & Biomolecular Chemistry. 5: 1915-23. PMID 17551641 DOI: 10.1039/B702649H |
0.443 |
|
2007 |
Boeglin D, Hamdan FF, Melendez RE, Cluzeau J, Laperriere A, Héroux M, Bouvier M, Lubell WD. Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor. Journal of Medicinal Chemistry. 50: 1401-8. PMID 17319653 DOI: 10.1021/Jm061343W |
0.594 |
|
2007 |
Ueda S, Oishi S, Wang ZX, Araki T, Tamamura H, Cluzeau J, Ohno H, Kusano S, Nakashima H, Trent JO, Peiper SC, Fujii N. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities. Journal of Medicinal Chemistry. 50: 192-8. PMID 17228861 DOI: 10.1021/Jm0607350 |
0.534 |
|
2006 |
Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot JM, Wang ZX, Peiper SC, Fujii N. Structure-activity relationship study on small peptidic GPR54 agonists. Bioorganic & Medicinal Chemistry. 14: 7595-603. PMID 16879969 DOI: 10.1016/J.Bmc.2006.07.009 |
0.38 |
|
2005 |
Cluzeau J, Lubell WD. Design, synthesis, and application of azabicyclo[X.Y.0]alkanone amino acids as constrained dipeptide surrogates and peptide mimics. Biopolymers. 80: 98-150. PMID 15795926 DOI: 10.1002/Bip.20213 |
0.544 |
|
2004 |
Van Cauwenberghe S, Simonin F, Cluzeau J, Becker JA, Lubell WD, Tourwé D. Structure-activity study of the ORL1 antagonist Ac-Arg-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH2. Journal of Medicinal Chemistry. 47: 1864-7. PMID 15027881 DOI: 10.1021/Jm031034V |
0.5 |
|
2004 |
Cluzeau J, Lubell WD. Conformationally constrained dipeptide surrogates with aromatic side-chains: synthesis of 4-aryl indolizidin-9-one amino acids by conjugate addition to a common alpha,omega-diaminoazelate enone intermediate. The Journal of Organic Chemistry. 69: 1504-12. PMID 14987004 DOI: 10.1021/Jo0355855 |
0.563 |
|
2001 |
Cluzeau J, Lubell WD. Remarkable asymmetric induction from remote stereocenters in conjugate addition chemistry for the synthesis of alkyl-branched α, ω-diaminoazelates Israel Journal of Chemistry. 41: 271-282. DOI: 10.1560/E1Uk-Etwj-Wlmf-Nha2 |
0.539 |
|
2001 |
Demange L, Cluzeau J, Ménez A, Dugave C. Synthesis of optically pure N-Boc-protected (2R,3R)- and (2R,3S)-3-fluoroprolines Tetrahedron Letters. 42: 651-653. DOI: 10.1016/S0040-4039(00)02030-X |
0.352 |
|
Show low-probability matches. |